drugset / Trial / NCT07544628
A Phase 1 Study of Navlimetostat Tablet Formulations
RandomizedCrossoverOpen-labelTreatment
Summary
This study aims to compare the PK of Navlimetostat after administration of a wet-granulation tablet versus the dry-granulation tablet formulation in healthy adult female
Timeline
- Start
- 2026-04-27
- Primary completion
- 2026-11-02
- Completion
- 2026-11-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Navlimetostat | Unknown | — | — |
Indications
No indication recorded.